• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. ARMADA; PERIPHERAL DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. ARMADA; PERIPHERAL DILATATION CATHETER Back to Search Results
Model Number B2050-100
Medical Device Problem Codes Inflation Problem (1310); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/31/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.H6: medical device problem code 2017- failure to follow steps / instructions.
 
Event or Problem Description
It was reported that the procedure was performed to treat the superficial femoral artery with mild tortuosity, mild calcification and 90% stenosis.The 5.0x100mm armada 35 percutaneous transluminal angioplasty (pta) catheter was not prepped per ifu and advanced over an unspecified 0.035 guide wire.The balloon was attempted to be inflated yet the balloon did not inflate as confirmed by angiogram.A non-abbott 5x100mm balloon was used to complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.Returned device analysis identified that the device leaked from the hub during testing.No additional information was provided.
 
Event or Problem Description
Subsequent to the initially filed mdr report: it was reported that a new unspecified 0.035 guide wire was used for the procedure.The gw was introduced into the guidewire port and the back end was used.No additional information was provided.
 
Additional Manufacturer Narrative
Visual inspection, functional testing, and sem analysis were performed on the returned device.The reported inflation issue was confirmed.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other similar complaints from this lot.It was reported that the device was not prepared (air aspiration) outside the anatomy.It should be noted that the percutaneous transluminal angioplasty (pta) armada 35 / armada 35 ll, global, instruction for use indicates to perform the steps to remove all air and verify the integrity of the pta catheter.Leave the catheter under negative pressure until the balloon is at the target lesion site.Then the device can be introduced the device into the vascular system.The balloon was ultimately sent to the scanning electron microscopy (sem) lab for further analysis.The sem report determined the leakage at the proximal end of the luer, at the guidewire port, may be attributed to mechanical damage.The leak area was on the outer surface of the guidewire lumen, near the opening of the inflation lumen of the dual lumen shaft.Mechanical damage was documented at the leak edge.Based on the reported information and the observations from the returned analysis, a definitive cause for the reported inflation issue could not be determined.Sem analysis determined the leakage at the proximal end of the luer, at the guidewire port, may be attributed to mechanical damage.Mechanical damage was documented at the leak edge.In this case, it is possible that the noted damage resulted from interaction with the guide wire during loading and/or inadvertent manipulation of the guide wire in the device; however, a conclusive cause cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARMADA
Common Device Name
PERIPHERAL DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key20616058
Report Number2024168-2024-12970
Device Sequence Number8874497
Product Code LIT
UDI-Device Identifier08717648155208
UDI-Public(01)08717648155208(17)270131(10)30801G1
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
K111899
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberB2050-100
Device Catalogue NumberB2050-100
Device Lot Number30801G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/07/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/14/2024
Supplement Date Received by Manufacturer12/06/2024
Initial Report FDA Received Date11/05/2024
Supplement Report FDA Received Date12/29/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
UNSPECIFIED 0.035 GUIDE WIRE
Patient SexUnknown
-
-